Skip to main content
MedComms & Advertising

8+ Years in MedComms

Launches, medical education, omnichannel campaigns, and MLR expertise across pharmaceutical brands.

Launches
MLR
HCP Tactics
Congress
Digital

Brands I've Worked On

Experience across diverse therapeutic areas and treatment modalities.

Novartis

KYMRIAH

Oncology (CAR-T Cell Therapy)

Novartis

GILENYA

Multiple Sclerosis

Novartis

Iptacopan

Rare Disease

Pfizer

COMIRNATY

COVID-19 Vaccine

Pfizer

PAXLOVID

COVID-19 Treatment

Pfizer

Velsipity

Immunology

Sanofi

Xenpozyme

Rare Disease

GSK

Gepotidacin

Infectious Disease

UCB

Staccato

CNS

Corium

Adlarity

CNS (Alzheimer's)

Daiichi Sankyo

ENHERTU

Oncology

CSL Behring

IDLVION

Hematology

CSL Behring

HEMGENIX

Hematology

Tactics I've Delivered

End-to-end delivery across the full spectrum of pharma marketing materials.

Detail Aids
MOA Videos
Websites
Videos
Animations
National Broadcasts
Microsites
CRM Campaigns
Congress Materials
Congress Booth Design
Product Theaters
Leave-Behinds
HCP Portals
Patient Education
Sales Training
Speaker Training
P2P
KOL Engagements
Launch Materials
Digital and Print Materials
Technical Operations
Holograms
Augmented Reality

Key Stories

Highlights from 8+ years in pharmaceutical marketing and medical communications.

KYMRIAH Launch Operations

Integral team member for the first FDA-approved CAR-T cell therapy launch, a landmark moment in oncology. Led team of 20 for MLR submissions across Veeva, oMAP, and eMAP platforms, achieving 90% approval rating (highest among peer agencies). Subsequently supported the Pediatric Indication expansion.

Historic first CAR-T approval | 90% MLR approval rate | Initial + Pediatric indications

Launch
MLR
Oncology
Cell Therapy
Pediatric
First-to-Market

Pfizer COVID-19 Digital Support

Led cross-functional teams (medical, creative, editorial, accounts) to deliver 5 Pfizer COVID-19 websites within accelerated one-month timelines. Navigated Emergency Use Authorization (EUA) and Conditional Marketing Authorization (CMA) requirements for COMIRNATY and PAXLOVID during global health emergency.

5 websites launched | EUA & CMA compliance | One-month accelerated delivery

Digital
Regulatory
Vaccines
EUA
COVID-19
Accelerated Timeline

IPG Account Leadership

Account Director overseeing $3M+ portfolios across hematology and immunology therapeutic areas. Led cross-functional teams spanning medical, editorial, creative, PM, and regulatory to deliver integrated tactical plans. Drove alignment between KOL insights, HCP engagement strategies, and brand objectives.

$3M+ portfolio management | Cross-functional leadership | Strategic account growth

Account Leadership
Strategy
Hematology
Immunology
$3M+ Portfolio
KOL Integration

Looking for MedComms Leadership?

Deep industry expertise in launches, MLR, and account leadership, combined with modern AI-enabled operational efficiency.